Enrichment | Pathway description | p-value | p. adjust | Gene symbol |
---|---|---|---|---|
KEGG | FoxO signaling pathway | 0.0324 | 0.0445 | FBXO32 |
KEGG | Axon guidance | 0.0446 | 0.0446 | UNC5D |
GO | protein phosphorylated amino acid binding | 0.0115 | 0.0319 | RTF1 |
GO | RNA polymerase II complex binding | 0.0119 | 0.0319 | RTF1 |
GO | RNA polymerase core enzyme binding | 0.0137 | 0.0319 | RTF1 |
GO | basal transcription machinery binding | 0.0162 | 0.0319 | RTF1 |
GO | basal RNA polymerase II transcription machinery binding | 0.0163 | 0.0319 | RTF1 |
GO | RNA polymerase binding | 0.0171 | 0.0319 | RTF1 |
GO | phosphoprotein binding | 0.0186 | 0.0319 | RTF1 |
GO | single-stranded DNA binding | 0.0253 | 0.0380 | RTF1 |
Reactome | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 0.0081 | 0.0323 | FBXO32 |
Reactome | Netrin-1 signaling | 0.0140 | 0.0323 | UNC5D |
Reactome | E3 ubiquitin ligases ubiquitinate target proteins | 0.0165 | 0.0323 | RTF1 |
Reactome | Formation of RNA Pol II elongation complex | 0.0171 | 0.0323 | RTF1 |
Reactome | RNA Polymerase II Transcription Elongation | 0.0171 | 0.0323 | RTF1 |
Reactome | FOXO-mediated transcription | 0.0182 | 0.0323 | FBXO32 |
Reactome | Protein ubiquitination | 0.0221 | 0.0323 | RTF1 |
Reactome | RNA Polymerase II Pre-transcription Events | 0.0234 | 0.0323 | RTF1 |
DO | lateral sclerosis | 0.0275 | 0.0813 | FBXO32 |
DO | amyotrophic lateral sclerosis | 0.0383 | 0.0813 | FBXO32 |
DO | motor neuron disease | 0.0462 | 0.0813 | FBXO32 |
DO | chronic obstructive pulmonary disease | 0.0542 | 0.0813 | FBXO32 |
DO | obstructive lung disease | 0.0755 | 0.0905 | FBXO32 |